September 1st saw the CPHI & PMEC China Pharmaceutical Industry Exhibition (Shenzhen) open in spectacular fashion at the Shenzhen Convention & Exhibition Center (Futian). This high-caliber event leverages its platform strengths to pool premium business resources and steer industry trends with innovative thinking, contributing to deeper regional collaboration and the building of a new highland for the pharmaceutical industry in South China and Asia.

As the dividends of reform policies continue fueling industrial growth, the pharmaceutical sector—in a critical phase of innovation and upgrading—still faces multiple challenges in both R&D and production. Morimatsu brought to attendees a sharp focus on smart, high-efficiency solutions, jointly mapping out a roadmap for industry innovation and upgrading to drive sustainable development in the pharmaceutical industry.

Beyond sharing technical expertise in the core processes of API and solid dosage manufacturing, Morimatsu showcased its subsidiary, MoriSora Technology’s total solution for lyophilization system – a standout feature of the exhibition and a major talking point for attendees.

Centered on the concept of functional unit integration, the lyophilization system solution organically combines modules such as lyophilizers, loading/unloading systems, and Grade A environmental barrier systems, offering dual-engine support of "equipment + services" with the following features:

1.Flexible Adaptation
Meets diverse product and capacity needs; supports functional expansion to comply with varying regulatory requirements.

2.Efficient and Energy-Saving
Optimizes Grade A zone space utilization, enhances drying efficiency, and significantly reduces energy consumption and operating costs.

3.Intelligent Control and Management
Centralized data management, supporting remote monitoring and maintenance; built-in computer validation framework, ensuring data integrity.

In this highly specialized and regulation-driven field of pharmaceutical equipment, we remain committed to delivering highly productive solutions, continuously deepening the integration of modular technology and service ecosystems to help clients navigate dual challenges of global competition and evolving regulations. Morimatsu, staying current with industry trends and steering development, collaborates to unlock new growth avenues for the pharmaceutical industry in the Greater Bay Area and Asia.

About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.